GILD

Nasdaq

GILEAD SCIENCES, INC.

Health Care, Biotechnology

$133.21

close 7 Aug 2026

+10.58%

52-week change

$165.31B

market cap

$108.46

$157.29

52-week range

Expected price

$127.83 – $156.24

Current price

$133.21

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)-50.08x

P/S (TTM)5.43x

P/B13.98x

EV/EBITDA (TTM)-90.10x

FCF yield (TTM)7.83%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average114.71x

P/E, sector median29.65x*

Price at 5-year median P/E—*

Indicated dividend yield2.46%

Forward — analyst consensus

Forward P/E (FY2026)—*

Forward P/E (FY2027)13.49x

Forward PEG—*

Consensus EPS FY2026 (24 analysts)-$0.4819

EPS growth (FY2026→FY2027)—

Revenue growth (FY2026)4.16%

Street view

Price target (mean)$157.41*

Target upside18.16%

Ratings (buy / hold / sell)22 / 7 / 0

FY2026 EPS revisions, 30d (up / down)8 / 4

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +4.69%10Y CAGR -7.45%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$133.21

Cash & equivalents—

Total debt$26.25B

Shares outstanding1.24B

Result

DCF price per share—

Current price$133.21

Margin of safety—

PV of years 1–10$109.50B

PV of terminal value$176.69B

Equity value—

Market-implied growth—

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$13.55B	$14.19B	$14.85B	$15.55B	$16.28B	$17.04B	$17.84B	$18.68B	$19.55B	$20.47B	$381.46B
PV	$12.55B	$12.16B	$11.79B	$11.43B	$11.08B	$10.74B	$10.41B	$10.09B	$9.78B	$9.48B	$176.69B

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026